Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution. Boulanger M, Molina E, Wang K, Kickler T, et al. Am J Med 2021;134:1029-1033.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boulanger M, Molina E, Wang K, Kickler T, et al. Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution. Am J Med 2021;134:1029-1033.
PMID: 33811876